Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy.
Giuliana Ribeiro de CarvalhoVagner Loduca LimaGlaucia Raquel Luciano da VeigaFernando AdamiBeatriz da Costa Aguiar AlvesEdimar Cristiano PereiraDavid FederFernando Luiz Affonso FonsecaPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
The current study showed that HbA1c values and the amount of leukocytes negatively interfere with the therapeutic response. Therefore, laboratory analyses of these parameters are recommended for diabetic patients undergoing the above-mentioned treatment.